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1. Introduction  
Mammalians have developed the part of the female genital tract, namely the uterus, to be a 
specific site that can receive embryo implantation. As a result, the mother must interact with 
the implanting embryo in the uterus, reconstruct maternal tissues during placentation and 
adapt maternal whole organs to accept embryo parasite. To induce the uterine environment to 
be favorable for embryo implantation, mammalian females in the reproductive stages 
periodically construct a unique endocrine organ, corpus luteum (CL), from the ovulated 
follicle. This newly constructed endocrine organ produces abundant amount of progesterone 
and induces the estrogen-primed endometrium to become a further differentiated stage that is 
suitable for embryo implantation (Yen, 1991). When the developing embryo enters the uterine 
cavity, a direct cross-talking of the embryo and the maternal endometrium is considered 
necessary to achieve a subsequent successful implantation of the embryo (Simón et al., 2001). 
However, the precise mechanisms of the initial step of human embryo implantation remain 
unknown. Recently, accumulating evidence suggests that local immune cells at the 
implantation site actively contribute to embryo implantation (Lea and Sandra, 2007; 
Yoshinaga, 2008). In this chapter, we introduce new mechanisms by which circulating blood 
immune cells contribute to embryo implantation by inducing endometrial differentiation and 
promoting embryo-maternal cross-talk.  
2. Regulation of ovarian function and differentiation by circulating immune cells 
2.1 Endocrine regulation of human CL of pregnancy 
In each menstrual cycle, human CL function continues only for 14 days. However, when 
becoming pregnant, the implanting embryo secretes human chorionic gonadotropin 
(HCG). This hormone is produced by the developing trophoblasts of the embryo and 
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secreted into maternal blood circulation immediately after embryo invasion within the 
endometrium. HCG shares a receptor with luteinizing hormone (LH) and stimulates the 
function of CL of menstrual cycle in the ovary. This hormone also induces its 
transformation into CL of pregnancy to further produce progesterone, which in turn 
maintains embryo implantation in the uterus. Accordingly, there is a systemic crosstalk 
between the implantation embryo and mother through blood circulation system from the 
very early stages of human pregnancy. In this process, CL of pregnancy is an essential 
organ and it has been believed that HCG is a major regulator of human CL of pregnancy 
(Yen, 1991)(Fig. 1).  
However, there are several lines of basic studies and clinical evidence to suggest that human 
CL of pregnancy is also regulated by different mechanisms (Rao et al., 1977; Shima et al., 
1987). For example, in patients with ectopic pregnancy or natural abortion, despite a high 
HCG level in blood, progesterone production by the CL decreases and abortion proceeds 
(Alam et al., 1999). Text books say that rapid and continuous increase in HCG concentration 
is necessary to maintain CL of pregnancy. However, LH/HCG receptor system does not 
need such a high concentration for its activation. On the other hand, chorionic gonadotropin 
is only detected in mare and primates (Murphy and Martinuk, 1991). Accordingly, 
regulatory mechanisms for CL of pregnancy are completely different among mammals. 
However, although many researchers have investigated additional essential hormones, no 
soluble factor other than HCG has been identified and the precise regulatory mechanisms 
remain unknown (Kratzer and Taylor, 1990). 
 
Fig. 1. Endocrine regulation of human early pregnancy 
When being pregnant, human chorionic gonadotropin (HCG) that shares a receptor with 
LH, is secreted from the invading embryo and transmitted to the maternal ovary from the 
uterus by systemic blood circulation. Then, HCG stimulates corpus luteum to produce 
progesterone and this ovarian hormone is in turn transmitted to the uterus to maintain 
embryo implantation. Accordingly, there is a cross-talk between embryo and mother by 
endocrine system from the very early stage of human pregnancy. 
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2.2 Immune regulation of human CL of pregnancy 
Based on the above background, we tried to identify the molecules that are expressed in 
human CL of pregnancy in order to clarify regulatory mechanism(s) that influence CL 
function and pregnancy. We found that several molecules that mediate interaction with T-
lymphocytes were expressed on the luteal cell surface in the human CL of pregnancy 
(Fujiwara et al., 1993; Hattori et al., 1995). In general, immune cells are considered to enhance 
CL regression (Pate and Keyes, 2001). However, since these molecules such as HLA-DR and 
leukocyte functional antigen (LFA)-3/CD58 appear during CL formation, we speculated 
that interaction with immune cells plays some role in the functional and morphological 
transition from CL of menstrual cycle to CL of pregnancy. 
After hatching, the human embryo takes an apposition, facing inner cell mass toward 
luminal epithelial layer, and then attaches to endometrial epithelial cells via trophectoderm 
layer. During this process, trophectoderm is activated to acquire invasive property and the 
attached embryo invades the endometrium as a mass through the epithelial layer, becoming 
buried within endometrial stromal tissue within 8-9 days after ovulation. Thereafter, 
trophoblast invasion transiently slows down and the lacunar spaces, which will become the 
intervillous spaces, are formed within the trophectoderm layer. Maternal blood gently flows 
in these spaces and then returns to the maternal systemic circulation (Boyd JD, Hamilton, 
1970). At this stage, HCG is abundantly produced by the trophectoderm and the secreted 
HCG is transmitted to the ovary through the blood circulation, stimulating corpus luteum to 
produce progesterone via the LH/HCG receptor. During formation of the lacunar spaces, 
maternal blood cells including peripheral blood mononuclear cells (PBMC: lymphocytes 
and monocytes) are also considered to infiltrate here and these cells also return to the 
maternal systemic circulation including those in the ovary.   
Taken together with the findings that the human CL expresses several molecules that can 
mediate direct interaction with T lymphocytes, we hypothesized that circulating immune 
cells contribute to the systemic crosstalk between embryo and mother (ovary) via blood 
circulation. It is theoretically sound to speculate that signals from the developing embryo in 
the genital tract are transmitted to the ovary by not only the endocrine system, but also the 
immune system, in other words, via not only soluble factors, but also circulating cells 
(Hattori et al., 1995) (Fig. 2).     
The maternal immune system recognizes the presence of the developing and implanting 
embryo in the Fallopian tube and the uterus by embryo- and species-specific signals such as 
degraded products of zona pellucida glycoprotein and/or HCG. Then, effector immune 
cells move to the ovary and the endometrium via blood circulation to regulate CL function 
and induce endometrial differentiation. The local immune cells at the implantation site also 
contribute to induction of embryo invasion, secreting chemoattractants by HCG stimulation.  
To prove this hypothesis, we investigated the effects of PBMC derived from pregnant 
women in early pregnancy on progesterone production by human luteal cells in culture. We 
found that PBMC derived from women in early pregnancy promoted progesterone 
production as much as that by HCG stimulation, suggesting that circulating blood immune 
cells in early pregnancy enhance CL function (Hashii et al., 1998). Based on these findings, 
we extended our hypothesis to the further concept that circulating immune cells transmit 
information about the presence of the developing embryo to various organs throughout the 
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whole body and induce adequate functional change or differentiation in these organs to 
facilitate embryo implantation (Fujiwara, 2006).   
 
Fig. 2. Dual regulation of human embryo implantation by hormones and circulating 
immune cells  
3. Regulation of endometrial differentiation by circulating immune cells 
In human CL, LH/HCG receptor expression was already disappeared on 14th day after 
ovulation (Takao et al., 1997). When becoming pregnant, serum HCG arise around 11 days 
after ovulation. However, at this stage CL regression has already started. So, to achieve 
smooth transformation into CL of pregnancy, it is reasonable to expect that immune cells 
transmit information of the developing embryo to CL before embryo implantation. To 
support this speculation, HLA-DR and leukocyte functional antigen (LFA)-3/CD58 that can 
mediate direct interaction with T lymphocytes were expressed on human CL during corpus 
luteum formation. 
3.1 Immune regulation of endometrial differentiation in mice 
To investigate the above idea, we first examined the effects of circulating immune cells on 
endometrial differentiation and embryo implantation using mouse implantation 
experiments. When blastocysts were transferred into the uterine cavity of pseudopregnant 
recipient mice that had been mated with vasectomized male mice, successful implantation 
was only achieved during 3-5 days after ovulation when the endometrium was adequately 
differentiated.  This period is called the “implantation window” (Psychoyos, 1993; Dey, 
1996). However, when spleen cells, stocked circulating immune cells, were obtained from 
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pregnant day 4 mice (before attachment stage) and were administered to pseudopregnant 
mice, embryo implantation was induced prior to the implantation window (1-2 days after 
ovulation) when embryos cannot normally be implanted (Takabatake et al., 1997a). Then we 
examined direct effect of spleen cells and observed that T-cell-rich population more 
effectively promoted embryo implantation (Takabatake et al., 1997b). In contrast to pregnant 
mice, spleen cells derived from diestrus or pseudopregnant mice had no effects. These 
findings indicated that before hatching stage, immune cells in early pregnancy have 
changed their functions to promote embryo implantation. This also suggests that developing 
embryo is necessary for functional change of immune cells.  
In order to examine the direct effects of the splenocytes on endometrial differentiation, we 
used a delayed implantation model in which pseudopregnant mice were treated with daily 
progesterone supplementation following an oophorectomy on post-ovulatory day 3. In this 
model, in the absence of ovarian estrogen, blastocysts that are transferred into the uterine 
cavity remain floating in the luminal spaces, and the exogenous administration of estrogen 
induces expression of leukemia inhibitory factor (LIF) in the endometrium, restarting 
embryo implantation (Bhatt et al., 1991). Interestingly, instead of estrogen, intravenous 
administration of splenocytes derived from early pregnancy restarted embryo implantation 
along with induction of LIF expression (Takabatake et al., 1997b). These results indicated 
that circulating immune cells could encourage early endometrial differentiation that was 
necessary for subsequent embryo implantation. These findings suggest that endometrial 
differentiation just prior to embryo attachment can be achieved by dual control of the 
endocrine and immune systems (Fig. 2).  
Notably, it was demonstrated that thymocytes from non-pregnant immature mice, 
especially CD8-negative population, could promote embryo implantation along with 
induction of LIF expression in the uterus. This indicates that there is a certain immune cell 
population that can induce endometrial differentiation and embryo implantation even in 
non-pregnant mice (Fujita et al., 1998).  
3.2 Immune regulation of human endometrial receptivity 
Implantation window is also supposed to exist in women. However, there has been no 
study to directly prove this window. Therefore, we then examined whether or not human 
endometrial receptivity really changes during menstrual cycle and immune cells can affect 
endometrial receptivity. To examine this issue, we first developed an attachment assay 
using a human choriocarcinoma-derived BeWo cell mass that mimics a human blastocyst 
and a human endometrial epithelial cell monolayer culture. In this assay, high attachment 
rates were observed in endometrial culture derived from women in the mid-luteal phase, 
supporting that there is an implantation window in human endometrium. Importantly, 
when these endometrial cells were co-cultured with autologous PBMC, attachment rates 
significantly increased in the culture derived from women in the late proliferative and early 
secretory phases, showing that autologous PBMC promote human endometrial cell 
receptivity in vitro (Kosaka et al., 2003). These findings led us to think about the possible 
clinical application of autologous circulating immune cells to treatment for patients 
suffering with repeated implantation failures. 
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4. Maternal recognition of the human developing embryos by the immune 
system 
4.1 HCG as a specific embryonal signal to the immune system 
In order to receive information of the presence of the human developing embryo, the 
immune system must recognize the embryo-specific signals from the developing embryo in 
the female genital tract. First, we focused on the embryo-specific hormone, HCG, which is 
secreted from the developing and implanting human embryo. In invasion assays using 
murine embryo and BeWo cells, PBMC derived from women in early pregnancy promoted 
murine trophectoderm and BeWo cell invasion more than those obtained from non-
pregnant women. It was also shown that this effect was exerted by soluble chemoattractive 
factors that were secreted by PBMC. Importantly, when PBMC derived from non-pregnant 
women were incubated with HCG, HCG-treated PBMC promoted invasion more than non-
treated PBMC (Nakayama et al., 2002; Egawa et al., 2002). These findings suggest that HCG 
can change PBMC functions to facilitate embryo implantation. 
Several decades ago, HCG crudely purified from urine was reported to suppress immune 
reactions (Adcock et al., 1973). However, it was later shown that highly purified HCG had 
no effect on lymphocyte function (Muchmore and Blaese, 1997). Accordingly, the effects of 
HCG on immune cell function have been controversial for a long time. Ten years ago, we 
found that recombinant-HCG enhanced IL-8 production by human monocytes at relatively 
high concentrations via activation of NF-B. HCG shares a receptor with LH to commonly 
access the LH/HCG receptor. However, the so-called LH/HCG receptor was not detected 
on the cell surface of monocytes. Therefore, it was speculated that there was a different 
pathway besides the LH/HCG-R system, which could respond to high HCG concentration. 
It should be noticed that HCG is an evolutionarily current hormone that is detected in 
primates (Cole, 2007). The most important difference between LH and HCG is the presence 
of abundant sugar chains at the C-terminal of the HCG -subunit. Notably, binding of HCG 
on the cell surface of the monocytes and HCG-induced IL-8 production were inhibited by an 
exogenous excess of mannose, suggesting that HCG can regulate PBMC function through 
sugar chain receptors, which is a primitive regulatory mechanism in the immune system 
(Kosaka et al., 2002). It should also be noted that the sugar chains of purified HCG are 
largely cleaved before urine production (Cole, 2009).  
A high concentration of HCG is locally produced at the embryo implantation site. It is well 
known that the initial change around the implantation site is an increase in vascular 
permeability, leading to recruitment of certain immune cells to the area. Recently, it was 
reported that human trophoblasts invading the implantation site produce 
hyperglycosylated HCG, and that the hyperglycosylated HCG up-regulates trophoblast 
invasion in humans (Handschuh et al., 2007). Therefore, it is reasonable to speculate that 
HCG stimulates endometrial immune cells to produce chemoattractants and vasodilators 
and that these cytokines in turn induce embryo invasion (Fujiwara, 2006).  
To support our proposal, Kane et al. reported that HCG induced proliferation of uterine 
natural killer cells via the mannose receptor (Kane et al., 2009). In addition, Schumacher et 
al., demonstrated that high HCG levels at very early pregnancy stages ensure regulatory T 
cells to migrate to the site of contact between paternal antigens and maternal immune cells 
and to orchestrate immune tolerance toward the fetus (Schumacher et al. 2009). Furthermore, 
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Wan et al. proposed that HCG contributed to the maternal-fetal tolerance during pregnancy 
by inducing dendritic cells toward a tolerogenic phenotype (Wan et al., 2008). 
4.2 Maternal recognition of the developing embryo in the Fallopian tube by the 
immune system 
The findings from mouse implantation experiments suggest that functional changes in the 
immune system have already occurred in the early stage of pregnancy when the developing 
embryo passes through the Fallopian tube. In support of this speculation, it was also 
reported that intraepithelial lymphocytes of human oviduct, which were identified as CD8-
positive T lymphocytes, expressed both estrogen receptor- and membrane progesterone 
receptor. The number of Ki-67- and estrogen receptor-positive intraepithelial lymphocytes 
fluctuated during menstrual cycle in the normal oviducts and significantly increased in 
tubal pregnancy oviducts, suggesting their involvement in immune reactions during early 
pregnancy (Ulziibat et al, 2006). 
In order to accurately identify the embryo, the maternal immune system must distinguish 
non-self tissues belonging to the same species from those of other organisms. The immune 
system must also discriminate between developing embryos and unfertilized eggs. 
However, since the embryo is surrounded by the zona pellucida, immune cells cannot 
directly interact with the embryo in the Fallopian tube. Therefore, it is speculated that the 
developing embryo actively releases species-specific and embryo-specific factors into the 
Fallopian tube. However, it appears difficult for the embryo to produce a sufficient amount 
of such soluble factors to successfully activate the maternal immune system at such an early 
stage in its development.    
Since it was shown that the sugar chains of the HCG effectively activate immune cells, we then 
paid attention to the zona pellucida that contains abundant glycoproteins. It is well known 
that the zona pellucida is composed of glycoproteins that mediate species-specific interaction 
between spermatozoa and oocytes (Florman and Ducibella, 2006). Accordingly, the zona 
pellucida can be considered an abundant store of species- and oocyte-specific glycoproteins. In 
addition, in contrast to unfertilized oocytes, the developing embryo actively degrades the zona 
pellucida. During fertilization, the zona pellucida of fertilized oocytes can be a target for 
acrosomal enzymes of sperm and cortical granules of oocytes (Oura and Toshimori, 1990; Tanii 
et al., 2001) and developing embryos further degrade the zona pellucida in order to achieve 
hatching. Thus, degradation products of zona pellucida glycoproteins may be released from 
fertilized oocytes/developing embryos into the Fallopian tube. Accordingly, we hypothesized 
that degradation products of zona pellucida glycoproteins can be an embryonal signal that 
transmits information about the presence of the developing embryo to the immune system in 
the female genital tract (Fujiwara et al., 2009).  
Taken together, we propose that degraded products of zona pellucida glycoprotein and 
HCG are important candidates for embryo- and species-specific signals for maternal 
recognition by the immune system (Fig. 1). 
5. Clinical application 
As a growing clinical problem in reproductive medicine, increasing attention has been paid 
to repeated implantation failure in infertile patients who had undergone in vitro fertilization 
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(IVF) therapy. Unfortunately, no effective therapy had been developed. Based on our 
original findings, we developed a novel therapy using autologous PBMC. In this treatment, 
autologous PBMC are pre-incubated with HCG and then administrated into the uterine 
cavity prior to blastocyst transfer in order to induce endometrial differentiation that 
facilitates subsequent embryo implantation. We applied this therapy to patients who had 
experienced implantation failure in IVF therapy and found that PBMC treatment effectively 
improved pregnancy and implantation rates (Yoshioka et al., 2006). Several possible 
mechanisms relevant to this procedure can be demonstrated as follows. 1) PBMC may 
induce endometrial differentiation that facilitates embryo attachment. 2) Although PBMC 
are autologous cells from the patient, the induction of PBMC by themselves is expected to 
evoke favorable inflammatory reactions in the uterine cavity in vivo. 3) PBMC can secrete 
proteases that may effectively change the function or structure of surface molecules 
expressed on endometrial luminal epithelial cells. 4) PBMC can move from the uterine 
cavity toward the endometrial stromal tissue, creating a leading pathway for subsequent 
embryo attachment and invasion (Yoshioka et al., 2006; Fujiwara et al., 2009b).  
 
Fig. 3. Clinical protocol of PBMC treatment in IVF therapy 
In our clinical protocol, PBMC are isolated at the time of oocyte pick-up, and activated with 
HCG. After 2-day incubation, PBMC are isolated again and the freshly collected PBMC are 
combined with the cultured PBMC and they are administrated into uterine cavity 3 days 
before blastocyst transfer.  
In accordance with these clinical findings, Ideta et al. reported that administration of 
autologous PBMC in the uterine cavity increases pregnancy rates in bovine embryo transfer 
(Ideta et al., 2009). In addition, it was also observed that HCG-non-treated autologous 
PBMC were effective for patient with repeated implantation failures in IVF therapy  
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(Okitsu et al., 2011). These findings suggest that the application of autologous PBMC is an 
effective therapy for infertile patients suffering from repeated implantation failures.   
6. Conclusion 
In conclusion, we described a novel concept that immune cells receive information about the 
presence of a developing embryo and transmit this information through blood circulation to 
the whole body, inducing functional changes or differentiation in various organs, which 
facilitate human embryo implantation in cooperation with the endocrine system. 
Importantly, when the endocrine mechanism does not adequately operate, alternative 
mechanisms involving the immune system can be applied to infertility therapy. In the 
future, further clarification of the precise mechanisms for maternal recognition of the 
developing embryo by the immune system will contribute to our understanding the 
physiology of human embryo implantation and to developing more effective therapies 
using autologous immune cells along with further improvement in the breeding of domestic 
animals. 
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